Medical Weight Loss Coaching Package – AOD 9604 (If Prescribed)

Includes medical consult, personalized dosing plan, and expert coaching

This coaching package includes an accountability coach and access to a licensed telehealth provider through our partner, Qualiphy. All prescriptions are issued only if medically appropriate after an independent consultation. If not approved, you will receive a full refund. We do not sell medication directly or prescribe. Peptides are dispensed solely by licensed U.S. compounding pharmacies upon medical approval.

AOD 9604 Injections: A Targeted Fat-Loss Solution

At SynRX, we deliver pharmaceutical-grade peptides backed by clinical research and provider oversight. AOD 9604 (Advanced Obesity Drug) is a modified fragment of human growth hormone (HGH), specifically developed to enhance fat metabolism without the side effects associated with full-length HGH.

Originally developed by Monash University, AOD 9604 activates the beta-3 adrenergic receptors and promotes lipolysis (fat breakdown) while inhibiting lipogenesis (fat formation). It’s most effective for those struggling with stubborn fat and slow metabolism—without increasing blood sugar or growth factor levels.

How AOD 9604 Works

• Stimulates Lipolysis Promotes the breakdown of stored body fat, especially in difficult areas like the abdomen, thighs, and arms.

• Inhibits Lipogenesis Reduces the formation of new fat cells even during caloric surplus.

• Non-GH-Mimetic Does not raise IGF-1 levels or affect insulin, making it a safe option for those avoiding HGH-related risks.

• Supports Recovery & Cartilage Repair Some evidence suggests benefits in joint health and cartilage regeneration.

Potential Benefits of AOD 9604 Injections

✅ Localized Fat Loss – Especially effective in reducing abdominal fat stores.

✅ No Effect on Blood Sugar or IGF-1 – Unlike traditional HGH.

✅ Improved Metabolic Rate – Enhances overall fat-burning potential.

✅ Safe for Long-Term Use – No negative effects on blood sugar or growth factors in clinical studies.

✅ Stackable with Other Peptides – Can be combined with CJC-1295, BPC-157, or GLP-1s for amplified results.

AOD 9604 Injection Product Details

• Form: Sterile compounded injectable solution

• Peptide: AOD 9604 (fragment 176–191)

• Administration: Subcutaneous injection

• Storage: Refrigerate after opening

• Dosing Protocol: 300–600 mcg daily or as directed by provider

• Purity: ≥ 99% pharmaceutical-grade

• Source: U.S. licensed compounding pharmacy only

Why Choose SynRX for AOD 9604?

At SynRX, we combine science-backed therapy with personalized coaching to help you get real results—not just a prescription.

• No grey-market or “research-only” peptides

• Third-party tested, pharmaceutical-grade compounds

• Licensed provider oversight with every program

• Customized dosing and accountability support

• 100% U.S.-based pharmacy fulfillment

Scientific Resources

• Heffernan M, et al. “Safety and efficacy of AOD 9604 in humans.” Obesity Research & Clinical Practice, 2014

• Ng FM, et al. “Mechanisms of action of the AOD 9604 peptide fragment.” Endocrinology Journal, 2006

• Sainsbury A, et al. “AOD9604 as a potential anti-obesity drug.” Monash University Research Review, 2003

Important Note: AOD 9604 is a prescription peptide intended only for use under medical supervision. It is not approved for unsupervised or recreational use and is dispensed solely through a licensed telehealth consultation and compounding pharmacy partner.